Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000250057 | SCV000319855 | likely benign | Cardiovascular phenotype | 2015-06-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001705394 | SCV000529988 | likely benign | not provided | 2020-10-16 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000419070 | SCV000712046 | likely benign | not specified | 2016-04-26 | criteria provided, single submitter | clinical testing | p.Ser30280Ser in exon 301 of TTN: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. It has been identified in 4/66738 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitu te.org; dbSNP rs756591209). |
Labcorp Genetics |
RCV001459883 | SCV001663737 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000419070 | SCV002050767 | likely benign | not specified | 2021-12-04 | criteria provided, single submitter | clinical testing |